Home Account PricesPerformance Funds Retirement College Education

New window: AdvantageVoice - Opening the door to investment conversations. Read our new blog.

Wells Fargo Advantage Emerging Markets Equity Fund – EMGAX

Class A

CUSIP 94984B389

Share Price 11-27-15 17.85

Daily Change -0.20

YTD Return -9.85%

Morningstar Category Diversified Emerging Mkts

Inception Date 09-06-1994

Fund Number 0663

Net Fund Assets as of 10-31-2015 $3,382,374,399.63

Overall Morningstar Rating™ (out of 562 funds)
as of 10-31-2015
View Details
Morningstar RatingMorningstar RatingMorningstar RatingMorningstar Rating

Fund Notes

  • The Emerging Markets Equity Fund is closed to most new investors. For further information, please see the section entitled "Additional Purchase and Redemption Information" in the SAI.
  • Read the Quarterly Fund Commentary (PDF).
  • Learn about the fund's key highlights by reading the fund profile sheet (PDF).

More Information

fundAcctNum = RKB7

Printer Friendly Profile
E-Mail a Friend
Click on the tabs below for additional information on this fund:

MORNINGSTAR RATINGS™ as of 10-31-2015

Category = Diversified Emerging Mkts

3-year Morningstar Rating™ (out of 562 funds)   Morningstar RatingMorningstar Rating

5-year Morningstar Rating™ (out of 371 funds)   Morningstar RatingMorningstar RatingMorningstar Rating

10-year Morningstar Rating™ (out of 170 funds)   Morningstar RatingMorningstar RatingMorningstar RatingMorningstar RatingMorningstar Rating

Overall Morningstar Rating™ (out of 562 funds)   Morningstar RatingMorningstar RatingMorningstar RatingMorningstar Rating

The Overall Morningstar Rating for a fund is derived from a weighted-average of the performance figures associated with its three-, five- and ten-year (if applicable) ratings, based on risk-adjusted returns. Click here for more information.

Morningstar® Style Box™as of 10-31-2015
Morningstar Style Box
Click here for more information.

Lipper Emerging Markets Funds

1-year   384 out of 773

3-year   344 out of 548

5-year   181 out of 363

10-year   15 out of 159

Past performance is no guarantee of future results.


    1-year 3-year 5-year 10-year Since Inception

Emerging Markets Equity Fund   NAV   -20.60%   -6.63%   -3.94%   5.71%   5.69%

POP   -25.17%   -8.45%   -5.07%   5.08%   5.40%

MSCI Emerging Markets Index (Net)       -19.28%   -5.27%   -3.58%   4.27%   --

Figures quoted represent past performance, which is no guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance shown without sales charges would be lower if sales charges were reflected. Current performance may be lower or higher than the performance data quoted and assumes the reinvestment of dividends and capital gains. Click here for current month-end performance.
Public offering price (POP) is the price of one share of a fund including any sales charges. Net asset value (NAV) is the value of one share of the fund excluding any sales charges. Had sales charges been included, performance would be lower.
For Class A shares, the maximum front-end sales charge is 5.75%. Performance including sales charge assumes the sales charge for the corresponding time period.


Net Expense Ratio – effective since 07-01-15   1.60%

Gross Expense Ratio   1.60%

The advisor has committed, through 02-28-17, to waive fees and/or reimburse expenses to the extent necessary to cap the fund's total annual fund operating expenses after fee waiver, excluding certain expenses, at 1.61%. After this time, the cap may be increased or terminated only with the approval of the Board of Trustees. Without this cap, the fund's returns would have been lower.


2014   -5.22%
2013   -2.59%
2012     12.49%
2011   -14.16%
2010     22.21%
2009     72.85%
2008   -47.61%
2007     33.47%
2006     46.21%
2005     32.56%

  • Not FDIC Insured
  • No Bank Guarantee
  • May Lose Value

Wells Fargo Advantage Funds

  • Individual Investors · 1-800-359-3379
  • Investment Professionals · 1-888-877-9275
  • Institutional Sales Professionals · 1-866-765-0778